ToolGen Incorporated (KOSDAQ: 199800)

Market Cap	328.60B
Revenue (ttm)	998.58M
Net Income (ttm)	-47.76B
Shares Out	8.54M
EPS (ttm)	-6,022.52
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,325
Open	39,700
Previous Close	39,900
Day's Range	38,250 - 41,150
52-Week Range	36,100 - 110,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Mar 21, 2025

About ToolGen

ToolGen Incorporated, a biotechnology company, focuses on the development of genome editing technology in South Korea. The company develops clustered regularly interspaced short palindromic repeats (CRISPR)-Cas9 gene scissors for gene editing in eukaryotic cells. It is involved in patent monetization, treatment, and seed businesses. ToolGen Incorporated was founded in 1999 and is based in Seoul, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1999
• Employees: 84
• Stock Exchange: KOSDAQ
• Ticker Symbol: 199800

Financial Performance

In 2023, ToolGen's revenue was 1.10 billion, an increase of 48.41% compared to the previous year's 743.46 million. Losses were -42.34 billion, 132.9% more than in 2022.